Charles Hicks
Overview
Explore the profile of Charles Hicks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan L, Henegar C, Marconi V, Gordon K, Hicks C, Vannappagari V, et al.
AIDS Res Ther
. 2024 Dec;
21(1):96.
PMID: 39709467
Background: Real-world data on treatment patterns and clinical outcomes for newer drugs, including integrase strand transfer inhibitors, among older people with human immunodeficiency virus (PWH) are limited. Methods: This cohort...
2.
Henegar C, Letang E, Wang R, Hicks C, Fox D, Jones B, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140667
After a decade of dolutegravir (DTG) use in various antiretroviral therapy combinations and in diverse populations globally, it is critical to identify HIV strains with reduced drug susceptibility and monitor...
3.
Mazzella A, Fried A, Hicks C
HeartRhythm Case Rep
. 2021 May;
7(4):216-219.
PMID: 34026499
No abstract available.
4.
Safeek R, Hill T, Hendricks A, Underwood D, Washington M, Guidici J, et al.
J Am Coll Emerg Physicians Open
. 2020 Oct;
1(4):487-493.
PMID: 33000075
Background: In 2006, the Centers for Disease Control and Prevention (CDC) recommended non-targeted, opt-out HIV screening in all healthcare settings, including emergency departments (EDs). Multiple HIV testing programs have been...
5.
Muluneh B, Richardson D, Hicks C, Jensen B, Zeidner J
J Clin Oncol
. 2019 Jul;
37(30):2719-2721.
PMID: 31310577
No abstract available.
6.
7.
Cachay E, Ballard C, Colwell B, Torriani F, Hicks C, Mathews W
AIDS Res Ther
. 2017 Sep;
14(1):56.
PMID: 28931406
Background: Clinicians are incorporating patient-reported outcomes in the management of HIV-infected persons co-infected with hepatitis C virus (HCV), but there are no validated inventories to monitor symptoms of patients during...
8.
Katrak S, Park L, Woods C, Muir A, Hicks C, Naggie S
Open Forum Infect Dis
. 2016 Oct;
3(3):ofw173.
PMID: 27704025
Hepatitis C virus (HCV) infection is a leading cause of cirrhosis and the primary cause of liver transplantation in the United States, and coinfection with human immunodeficiency virus (HIV) increases...
9.
Tebas P, Kumar P, Hicks C, Granier C, Wynne B, Min S, et al.
AIDS
. 2015 Sep;
29(18):2459-64.
PMID: 26355674
Objective: Antiretroviral therapy initiation has been linked to bone mineral density and bone biomarker changes. We assessed long-term bone turnover biomarker effects over 144 weeks in patients initiating dolutegravir (DTG)...
10.
Naggie S, Patel K, Yang L, Chow S, Johnson V, Guyton J, et al.
Open Forum Infect Dis
. 2015 Jun;
2(2):ofv066.
PMID: 26110167
We evaluated the impact of antiretroviral-induced dyslipidemia on hepatitis C virus (HCV) biogenesis in human immunodeficiency virus (HIV)/HCV coinfected patients. This study used serum samples from antiretroviral-naive HIV/HCV patients initiating...